Steven Perrin

Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.

ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA.

Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ.

Part of Sanofi, Hoechst Ariad Genomics Center Llc is a research center for genomics. The company is based in Cambridge, MA. Hoechst Ariad Genomics Center was acquired by Hoechst Marion Roussel SA from ARIAD Pharmaceuticals, Inc. on January 04, 2000 for $40 million.

ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA.

Anelixis Therapeutics, Inc. operates as a clinical stage, privately held biotechnology company. It develops treatments for patients with neurodegenerative disease, people requiring an organ or cell based transplant, as well as people with an autoimmune disease. The company was founded by Steve Perrin in 2015 and is headquartered in Cambridge, MA.